NCT01025479已完成不适用
Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen Agent
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 829
- 试验地点
- 1
- 主要终点
- To define prevalence rate of osteoporosis in Prostate cancer patients who take LHRH antagonist or anti androgen (include MAB) at the stage of before treatment or it's initial stage.
研究概览
简要总结
Prevalence rate of osteoporosis and it's actual management condition in Prostate cancer patients who takes LHRH antagonist and anti androgen
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •pathologic confirmation of prostate cancer
- •patients who are taking LHRH antagonist or anti- androgen or both of them within 6 months since starting.
排除标准
- •patients who are hard to be analysed by limitation of chart record according to investigators'discretion
- •patients who already have been registered in this study
结局指标
主要结局
To define prevalence rate of osteoporosis in Prostate cancer patients who take LHRH antagonist or anti androgen (include MAB) at the stage of before treatment or it's initial stage.
次要结局
- To assess whether proper osteoporosis prevention and treatment was given or not according to osteoporosis treatment guideline in prostate cancer patients who are enrolled in this study.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate CancerProstate CancerOsteoporosisNCT00043069Alliance for Clinical Trials in Oncology71
Unknown
不适用
Prevalence of Osteoporosis in Patients Who Uses Inhaled SteroidsOsteoporosisNCT01246375Tel-Aviv Sourasky Medical Center20
Unknown
3 期
Osteoporosis Among Men Treated With Androgen Deprivation for Prostate CancerAndrogen Deprivation TherapyProstate CancerOsteoporosisNCT00957606Odense University Hospital100
已完成
不适用
Osteoporosis Screening TrialOsteoporosisNCT01677637Elpen Pharmaceutical Co. Inc.5,500
招募中
不适用
BONE MINERAL DENSITY IN PROSTATE CANCER PATIENTS TREATED WITH ANDROGEN DEPRIVATION THERAPYosteoporosisbone loss1001329610038364NL-OMON37103Sint Franciscus Gasthuis51